Thrombolytics for Intermediate-Risk Pulmonary Embolisim: Are We There Yet?


Related Videos (49)

In this video, Jay GIri, MD, Director, Peripheral Intervention at Penn Medicine, offers an overview of thrombolytic therapy for pulmonary embolism. Dr Giri’s discussion includes a comparison of thrombolytics to standard anticoagulation therapy, an overview of the PEITHO trial of the tissue plasminogen activator tenecteplase, catheter-directed thrombolysis and age-specific recommendations for each treatment.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®